AFL Quote, Financials, Valuation and Earnings

AMERISAFE has a net margin of 34.59% compared to Aflac's net margin of 17.82%. Aflac's return on equity of 22.22% beat AMERISAFE's return on equity of 18.9%.

Aflac has a consensus price target of $106.00, signalling downside risk potential of -5.15%. On the other hand AMERISAFE has an analysts' consensus of $57.67 which suggests that it could grow by 8.68%. Given that AMERISAFE has higher upside potential than Aflac, analysts believe AMERISAFE is more attractive than Aflac.

Aflac has a beta of 0.811, which suggesting that the stock is 18.859% less volatile than S&P 500. In comparison AMERISAFE has a beta of 0.340, suggesting its less volatile than the S&P 500 by 65.96%.

Aflac has a quarterly dividend of $0.58 per share corresponding to a yield of 1.86%. AMERISAFE offers a yield of 2.83% to investors and pays a quarterly dividend of $0.39 per share. Aflac pays 19.97% of its earnings as a dividend. AMERISAFE pays out 154.12% of its earnings as a dividend. Aflac's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but AMERISAFE's is not.

Aflac quarterly revenues are $5.5B, which are larger than AMERISAFE quarterly revenues of $74M. Aflac's net income of $1.9B is higher than AMERISAFE's net income of $13.2M. Notably, Aflac's price-to-earnings ratio is 11.64x while AMERISAFE's PE ratio is 18.36x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aflac is 3.30x versus 3.29x for AMERISAFE. Usually stocks with elevated PS ratios are considered overvalued.

CNO Financial Group has a net margin of 34.59% compared to Aflac's net margin of 15.14%. Aflac's return on equity of 22.22% beat CNO Financial Group's return on equity of 16.56%.

Aflac has a consensus price target of $106.00, signalling downside risk potential of -5.15%. On the other hand CNO Financial Group has an analysts' consensus of $44.00 which suggests that it could grow by 11.22%. Given that CNO Financial Group has higher upside potential than Aflac, analysts believe CNO Financial Group is more attractive than Aflac.

Aflac has a beta of 0.811, which suggesting that the stock is 18.859% less volatile than S&P 500. In comparison CNO Financial Group has a beta of 0.897, suggesting its less volatile than the S&P 500 by 10.268%.

Aflac has a quarterly dividend of $0.58 per share corresponding to a yield of 1.86%. CNO Financial Group offers a yield of 1.62% to investors and pays a quarterly dividend of $0.16 per share. Aflac pays 19.97% of its earnings as a dividend. CNO Financial Group pays out 16.76% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Aflac quarterly revenues are $5.5B, which are larger than CNO Financial Group quarterly revenues of $1.1B. Aflac's net income of $1.9B is higher than CNO Financial Group's net income of $166.1M. Notably, Aflac's price-to-earnings ratio is 11.64x while CNO Financial Group's PE ratio is 10.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aflac is 3.30x versus 0.96x for CNO Financial Group. Usually stocks with elevated PS ratios are considered overvalued.

MetLife has a net margin of 34.59% compared to Aflac's net margin of 6.92%. Aflac's return on equity of 22.22% beat MetLife's return on equity of 15.21%.

Aflac has a consensus price target of $106.00, signalling downside risk potential of -5.15%. On the other hand MetLife has an analysts' consensus of $96.14 which suggests that it could grow by 26.65%. Given that MetLife has higher upside potential than Aflac, analysts believe MetLife is more attractive than Aflac.

Aflac has a beta of 0.811, which suggesting that the stock is 18.859% less volatile than S&P 500. In comparison MetLife has a beta of 0.895, suggesting its less volatile than the S&P 500 by 10.508%.

Aflac has a quarterly dividend of $0.58 per share corresponding to a yield of 1.86%. MetLife offers a yield of 2.87% to investors and pays a quarterly dividend of $0.55 per share. Aflac pays 19.97% of its earnings as a dividend. MetLife pays out 39.02% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Aflac quarterly revenues are $5.5B, which are smaller than MetLife quarterly revenues of $18.4B. Aflac's net income of $1.9B is higher than MetLife's net income of $1.3B. Notably, Aflac's price-to-earnings ratio is 11.64x while MetLife's PE ratio is 12.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aflac is 3.30x versus 0.77x for MetLife. Usually stocks with elevated PS ratios are considered overvalued.

Unum Group has a net margin of 34.59% compared to Aflac's net margin of 10.88%. Aflac's return on equity of 22.22% beat Unum Group's return on equity of 17.03%.

Aflac has a consensus price target of $106.00, signalling downside risk potential of -5.15%. On the other hand Unum Group has an analysts' consensus of $93.92 which suggests that it could grow by 18.53%. Given that Unum Group has higher upside potential than Aflac, analysts believe Unum Group is more attractive than Aflac.

Aflac has a beta of 0.811, which suggesting that the stock is 18.859% less volatile than S&P 500. In comparison Unum Group has a beta of 0.458, suggesting its less volatile than the S&P 500 by 54.171%.

Aflac has a quarterly dividend of $0.58 per share corresponding to a yield of 1.86%. Unum Group offers a yield of 2.05% to investors and pays a quarterly dividend of $0.42 per share. Aflac pays 19.97% of its earnings as a dividend. Unum Group pays out 16.67% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Aflac quarterly revenues are $5.5B, which are larger than Unum Group quarterly revenues of $3.2B. Aflac's net income of $1.9B is higher than Unum Group's net income of $348.7M. Notably, Aflac's price-to-earnings ratio is 11.64x while Unum Group's PE ratio is 8.37x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aflac is 3.30x versus 1.16x for Unum Group. Usually stocks with elevated PS ratios are considered overvalued.